BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Johnstone EK, Pfleger KD. Receptor-Heteromer Investigation Technology and its application using BRET. Front Endocrinol (Lausanne) 2012;3:101. [PMID: 22936924 DOI: 10.3389/fendo.2012.00101] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Jockers R. Comment on "The Use of BRET to Study Receptor-Protein Interactions". Front Endocrinol (Lausanne) 2014;5:3. [PMID: 24478757 DOI: 10.3389/fendo.2014.00003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
2 Köster L, Carbon M, Correll CU. Emerging drugs for schizophrenia: an update. Expert Opinion on Emerging Drugs 2014;19:511-31. [DOI: 10.1517/14728214.2014.958148] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
3 Kowalik A, Majerek M, Mrowiec K, Solich J, Faron-górecka A, Woźnicka O, Dziedzicka-wasylewska M, Łukasiewicz S. Dopamine D2 and Serotonin 5-HT1A Dimeric Receptor-Binding Monomeric Antibody scFv as a Potential Ligand for Carrying Drugs Targeting Selected Areas of the Brain. Biomolecules 2022;12:749. [DOI: 10.3390/biom12060749] [Reference Citation Analysis]
4 O'Brien SL, Johnstone EKM, Devost D, Conroy J, Reichelt ME, Purdue BW, Ayoub MA, Kawai T, Inoue A, Eguchi S, Hébert TE, Pfleger KDG, Thomas WG. BRET-based assay to monitor EGFR transactivation by the AT1R reveals Gq/11 protein-independent activation and AT1R-EGFR complexes. Biochem Pharmacol 2018;158:232-42. [PMID: 30347205 DOI: 10.1016/j.bcp.2018.10.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
5 Susec M, Sencanski M, Glisic S, Veljkovic N, Pedersen C, Drinovec L, Stojan J, Nøhr J, Vrecl M. Functional characterization of β2-adrenergic and insulin receptor heteromers. Neuropharmacology 2019;152:78-89. [PMID: 30707913 DOI: 10.1016/j.neuropharm.2019.01.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
6 Zhou Y, Meng J, Xu C, Liu J. Multiple GPCR Functional Assays Based on Resonance Energy Transfer Sensors. Front Cell Dev Biol 2021;9:611443. [PMID: 34041234 DOI: 10.3389/fcell.2021.611443] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Johnstone EKM, Pfleger KDG. Profiling novel pharmacology of receptor complexes using Receptor-HIT. Biochem Soc Trans 2021;49:1555-65. [PMID: 34436548 DOI: 10.1042/BST20201110] [Reference Citation Analysis]
8 Lai WY, Mueller A. Latest update on chemokine receptors as therapeutic targets. Biochem Soc Trans 2021;49:1385-95. [PMID: 34060588 DOI: 10.1042/BST20201114] [Reference Citation Analysis]
9 Jaeger WC, Armstrong SP, Hill SJ, Pfleger KD. Biophysical Detection of Diversity and Bias in GPCR Function. Front Endocrinol (Lausanne) 2014;5:26. [PMID: 24634666 DOI: 10.3389/fendo.2014.00026] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
10 Pickering RJ, Tikellis C, Rosado CJ, Tsorotes D, Dimitropoulos A, Smith M, Huet O, Seeber RM, Abhayawardana R, Johnstone EK, Golledge J, Wang Y, Jandeleit-Dahm KA, Cooper ME, Pfleger KD, Thomas MC. Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis. J Clin Invest 2019;129:406-21. [PMID: 30530993 DOI: 10.1172/JCI99987] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
11 Ayoub MA, See HB, Seeber RM, Armstrong SP, Pfleger KD. Profiling epidermal growth factor receptor and heregulin receptor 3 heteromerization using receptor tyrosine kinase heteromer investigation technology. PLoS One 2013;8:e64672. [PMID: 23700486 DOI: 10.1371/journal.pone.0064672] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
12 Gomes I, Ayoub MA, Fujita W, Jaeger WC, Pfleger KD, Devi LA. G Protein-Coupled Receptor Heteromers. Annu Rev Pharmacol Toxicol 2016;56:403-25. [PMID: 26514203 DOI: 10.1146/annurev-pharmtox-011613-135952] [Cited by in Crossref: 168] [Cited by in F6Publishing: 140] [Article Influence: 24.0] [Reference Citation Analysis]
13 Johnstone EKM, See HB, Abhayawardana RS, Song A, Rosengren KJ, Hill SJ, Pfleger KDG. Investigation of Receptor Heteromers Using NanoBRET Ligand Binding. Int J Mol Sci 2021;22:1082. [PMID: 33499147 DOI: 10.3390/ijms22031082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zamel IA, Palakkott A, Ashraf A, Iratni R, Ayoub MA. Interplay Between Angiotensin II Type 1 Receptor and Thrombin Receptor Revealed by Bioluminescence Resonance Energy Transfer Assay. Front Pharmacol 2020;11:1283. [PMID: 32973514 DOI: 10.3389/fphar.2020.01283] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
15 Johnstone EKM, Ayoub MA, Hertzman RJ, See HB, Abhayawardana RS, Seeber RM, Pfleger KDG. Novel Pharmacology Following Heteromerization of the Angiotensin II Type 2 Receptor and the Bradykinin Type 2 Receptor. Front Endocrinol (Lausanne) 2022;13:848816. [PMID: 35721749 DOI: 10.3389/fendo.2022.848816] [Reference Citation Analysis]